Novel role of gastrin releasing peptide-mediated signaling in the host response to influenza infection.
Ontology highlight
ABSTRACT: Gastrin-releasing peptide (GRP) is an evolutionarily well-conserved neuropeptide that was originally recognized for its ability to mediate gastric acid secretion in the gut. More recently, however, GRP has been implicated in pulmonary lung inflammatory diseases including bronchopulmonary dysplasia, chronic obstructive pulmonary disease, emphysema, and others. Antagonizing GRP or its receptor mitigated lethality associated with the onset of viral pneumonia in a well-characterized mouse model of influenza. In mice treated therapeutically with the small-molecule GRP inhibitor, NSC77427, increased survival was accompanied by decreased numbers of GRP-producing pulmonary neuroendocrine cells, improved lung histopathology, and suppressed cytokine gene expression. In addition, in vitro studies in
SUBMITTER: Shirey KA
PROVIDER: S-EPMC6301097 | biostudies-literature | 2019 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA